| 195 interview results |
|
-
Contributor: Hassan Bibi
Posted: 06/13/2013 12:00:00 AM EDT
In this interview Hassan Bibi, Regional Regulatory Affairs Director NEWAAT - Janssen Pharmaceutical companies of Johnson and Johnson, talks about overcoming the 3 main challenges with regards to meeting regulatory approval and improving distribution operations across the Middle East. Read more Contributor: Greer Deal
Posted: 06/07/2013 12:00:00 AM EDT
Greer Deal, Director of Global Regulatory Services (GRS) and co-editor for the Membersnewsletter, InTouch, of The Organisation for Professionals in Regulatory Affairs (TOPRA) speaks to Pharma IQ about regulatory growing-pains in emerging economies and how governments and industry can work closer to develop regulation which works for both parties. Read more Contributor: Bertil Lindmark
Posted: 06/03/2013 12:00:00 AM EDT
In this, the latest in our Boardroom Series of interviews, Bertil Lindmark praises the manoeuvrability of smaller pharma companies. He argues that the current in vivo models need revising and that single-point interventions may not be the best strategy for pharmaceuticals Read more Contributor: Andrea Charles
Posted: 05/24/2013 12:00:00 AM EDT
"Though investor interest in biotech companies has risen, they are still surprisingly out of favour in many markets, despite their strong growth prospects. That's mainly because they are risky - and in a specialised IP-driven way that many investors are uncomfortable with - and because they tend to have poor cashflow," said Ana Nicholls, Healthcare Analyst at The Economist Intelligence Unit. Read more Contributor: Carlos Camozzi
Posted: 05/14/2013 12:00:00 AM EDT
Blockbusted. In this Interview Orphazyme's Chief Medical Officer Carlos Camozzi argues that a future based on finding the next blockbuster will be difficult and that real advances can be made by shifting focus onto diagnostics and treatments for rare diseases. Read more Contributor: Mark McHale
Posted: 05/10/2013 12:00:00 AM EDT
In this exclusive interview, Dr Mark McHale, CSO of ASLAN Pharmaceuticals, located in Singapore, shares insight into how a small-to-medium pharma company operates and continues to be on the crest of the wave. Read more Contributor: Mark McHale
Posted: 05/10/2013 12:00:00 AM EDT
In Part 2 of this Boardroom Series interview, Mark McHale, CSO of ASLAN Pharmaceuticals, located in Singapore, shares his insights on the biggest challenges in drug development right now and the best CROs in the industry to work with. Read more Contributor: Mark McHale
Posted: 05/10/2013 12:00:00 AM EDT
In this interview, Mark McHale, CIO of ASLAN Pharmaceuticals, located in Singapore, shares insight into how a small-to-medium pharma company operates and continues to be on the crest of the wave. Read more Contributor: Shawn Siegel
Posted: 04/29/2013 12:00:00 AM EDT
Michael Burdick has 10 years of experience as a Special Agent with the FAA. In advance of his talk at the BioLogistics Summit, he shares some common pitfalls of transporting biologics and the best way to overcome those challenges. Read more Contributor: Mary Foster
Posted: 04/29/2013 12:00:00 AM EDT
Industry veteran Mary Foster is the chair of the USP's Committee on Packaging, Storage and Distribution. In advance of her speaking engagement at the BioLogistics Summit, we were lucky enough to chat with her about the regulatory challenges of transporting and distributing clinical trial materials and biologics. Read more Contributor: Ryta Kuzel
Posted: 04/29/2013 12:00:00 AM EDT
The European Commission implemented new laws regarding packaging for drugs that have a potential safety risk requiring them to be marked with an inverted black triangle. Ryta Kuzel, Director and Owner of VigiReg Consulting Ltd, which specialises in Pharmacovigilance auditing and Regulatory Affairs, explains the impact of these new regulations and gives a summary of the regulatory framework requirements for pharmaceuticals in Europe. Read more
195 interview results Advertisement
Events of Interest-
Compound Management & Integrity Online 2011
November 14, 2011
Register Now -
Regenerative Medicine and Barriers to Commercialisation Online Summit 2011
October 25, 2011
Register Now -
Electronic Laboratory Notebooks Online
December 2, 2011
Register Now -
Drive Successful Commercial Product Launches through Effective Key Packaging
February 7, 2013
Register Now
Pharma IQ is an online community for finding Pharma information, discussing ideas, and sharing Pharmaceutical and Biotechnology best practices.
Top Rated-
Being An Instrument of Change Contributor:
Tags: Jon Wetzel | change management | leadership
5.0 stars :
-
GSK Lead the Way with Staff Training for Disposables Implementation Contributor:
Tags: Disposable Solutions | Single Use Systems | GSK
5.0 stars :
-
New EU Regulations Contributor:
Tags: Deepa Arora | Pharmacovigilance | New EU Regulations
5.0 stars :
Advertisement
Most Read-
The Top 10 Biggest Pharmaceutical Companies: Who's Recruiting?
Pharmaceutical Jobs | Top 10 Biggest Pharmaceutical Employers | Pfizer
-
Intellectual Property Protection Solutions for Pharma and Biotech - Part 2
out licensing | outlicensing | Brainloop
-
...If it Quacks Like a Duck, it's Homeopathy
vaccination | public health | homeopathy
Reach Pharma professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.
Learn More >>
Learn how to sponsor a webinar with us?
Join today and interact with a vibrant network of pharma professionals, keeping up to date with the pharma industry by accessing our wealth of Pharma articles, videos, online seminars, live conferences and more.
Sign Up Today!Pharma IQ, a division of IQPC
2013 All rights reserved. Use of this site constitutes
acceptance of our User Agreement and Privacy Policy.
Careers With IQPC | Contact Us | Unsubscribe to Bizo | About Us | Cookie Policy
Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!